Policy

This retrospective cohort study compared the results of 5 Medicare Shared Savings Program accountable care organizations (ACOs) vs both ACO benchmarks and regional comparators over 4 years.

Innovative therapies for rare diseases such as spinal muscular atrophy (SMA), when paid for by public budgets in the European Union and elsewhere, are often managed by agreements between payers and drug companies, but details can be hard to discern.

In part 2 of a 2-part series, we look at the mental health risks affecting 9/11 rescuers, the lessons learned that apply to health care workers during the current pandemic, as well as continued barriers to care.

The FDA misses the deadline to pull e-cigarette products from the market; Los Angeles public schools require COVID-19 vaccines for those over age 12; rates of still births are on the rise in Mississippi.

The Department of Labor rules will affect employers with 100 or more workers.

The administration said it would make the results of its drug price negotiations with manufacturers, as well as its approach to value-based care models, open to a variety of payers.

Symptoms of late-stage chronic obstructive pulmonary disease (COPD) were more controlled when patients received palliative care, according to the Swedish study.

South Dakota executive order controls distribution of abortion medication and telemedicine abortions; some states receive funds to improve access to affordable health insurance; Idaho activates “crisis standards of care” due to volume of COVID-19 patients in hospitals.

Researchers have found that the COVID-19 pandemic has caused potentially millions of children to miss routine vaccines. During a time of back-to-school excitement and reversals of transmission prevention efforts in some states, children may be at risk of facing a slew of non-COVID-19 viral outbreaks.

On this episode of Managed Care Cast, we speak with one of the authors of a recent book looking at the erosion of trust in health care, the factors that influence trust, and what can be done to restore trust.

For patients with diffuse large B-cell lymphoma (DLBCL), PET/CT scans conducted in the first cycle of salvage therapy can predict for response, according to a study.

Members of Congress ask the FDA for documents relating to Aduhelm's controversial approval; outside experts will advise the FDA on booster shots; nursing shortages intensify.

A new Texas law ending abortions after 6 weeks takes effect, angering the American College of Obstetricians and Gynecologists; the CDC says mortality rates may not go back to normal until 2023; a Senate version of a bill aimed at lowering drug prices would only impact Medicare.

On this episode of Managed Care Cast, we speak with Ellen Kelsay, president and CEO of the Business Group on Health, on the findings from her organization's 2022 Large Employers’ Health Care Strategy and Plan Design Survey.

On this episode of Managed Care Cast, Laalitha Surapaneni, MD, MPH, an assistant professor of medicine at the University of Minnesota, describes her work in bringing awareness to the health impacts of climate change.

Pfizer's COVID-19 vaccine has gained full approval from the FDA.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

President Joe Biden pushes back against governors banning school mask mandates; family behind Purdue Pharma refuses to pay settlement for opioid suit without legal protections; the Environmental Protection Agency (EPA) bans a pesticide linked to health issues in children.

Top US health officials outlined plans for rolling out COVID-19 booster shots to all American adults beginning in September, while CMS announced that nursing homes will be required to implement mandatory vaccinations for staff.

Recent research showed that patients with Medicaid are more likely than commercially insured patients to have worsened end-of-life experience and that Black patients with breast cancer fare worse than other ethnic groups when it comes COVID-19 outcomes.

President Joe Biden pushes for measures aimed at lowering drug prices; the Supreme Court allows a vaccine mandate imposed by Indiana University to stand; heat advisories issued for almost 200 million Americans.

The meeting comes a day after the FDA approved a third dose of a COVID-19 vaccine from Pfizer-BioNTech and Moderna in people who have received organ transplants or have other conditions that have damaged their immune systems.

This study provides the first evidence on how Marketplace insurers are altering their marketing in response to changes in competitive pressure over time.

Survey results underscore parents’ frustration with insurers when it comes to caring for their children with rare diseases.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

FDA reportedly aims to fully approve Pfizer-BioNTech COVID-19 vaccine by early next month; Biogen’s Alzheimer drug sees little uptake; majority of Americans over 65 have received at least 1 dose of a COVID-19 vaccine.

Seventy percent of Americans have received at least 1 dose of a COVID-19 vaccine; CMS releases payment rules for fiscal year 2022; alcohol linked to over 700,000 new cancer diagnoses in 2020.

The study was conducted to shed more light on the growing issue of polypharmacy, an issue that is expected to increase as the US population ages.

Gary Lyman, MD, MPH, an oncologist and hematologist, discusses how financial incentives, concerns for patients, and interchangeability impact biosimilar prescribing patterns.

Drug optimization in older adults improved outcomes in this retrospective study.